👀 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

IBM shares price target lifted, outperform on strong outlook

EditorNatashya Angelica
Published 10/10/2024, 08:41 AM
© Reuters.
IBM
-

On Thursday, RBC Capital Markets updated its stance on IBM (NYSE:IBM) shares, raising the price target to $250 from the previous $211, while keeping an Outperform rating on the stock. The adjustment follows observable improvements in market sentiment and financial support from the company's free cash flow (FCF).

The firm noted a consistent increase in thematic inquiries, which indicates growing investor interest. The expectation set by IBM's management for Red Hat's business to pick up speed in the second half of the year was highlighted as a key factor. The first half's performance was attributed to better-than-anticipated infrastructure results and the contribution of GenAI to consulting revenues, despite encountering challenges in discretionary spending.

RBC Capital's outlook for IBM is buoyed by the tech giant's increasing software traction, especially from its subsidiary Red Hat. The analyst's commentary underscored the company's effective management and robust free cash flow, which are seen as the main drivers for the raised price target. This move reflects confidence in IBM's ability to enhance its efficiency and capitalize on a stabilizing macroeconomic environment.

The new price target of $250 represents a significant increase and signals RBC Capital's positive expectations for IBM's financial performance and strategic initiatives. The firm maintains its Outperform rating, suggesting that IBM's stock is projected to perform better than the overall market or sector in the coming months.

In other recent news, IBM has been the subject of significant developments. The company's third-quarter earnings report is anticipated by BofA Securities, which maintained a Buy rating on IBM and increased the price target to $250. The firm projects revenues and earnings per share (EPS) of $14.9 billion and $2.22, respectively. IBM's recent advancements in quantum computing, specifically the installation of its advanced processor, the IBM Quantum (NASDAQ:QMCO) Heron, have resulted in significant performance enhancements.

IBM has also been recognized by Evercore ISI, which maintained an Outperform rating, and Bernstein SocGen Group and Goldman Sachs, which maintained their Market Perform and Conviction Buy ratings, respectively. The company has been active in strategic collaborations, notably with NASA and Oak Ridge National Laboratory to launch a new open-source AI model for climate forecasting.

IBM's recent acquisitions of Kubecost and Accelalpha are expected to expand its hybrid cloud cost management capabilities and enhance its Oracle (NYSE:ORCL) consulting capabilities, respectively. These are recent developments that reflect IBM's ongoing commitment to innovation and strategic growth.

InvestingPro Insights

RBC Capital's optimistic outlook on IBM aligns with several key metrics and insights from InvestingPro. The company's stock has shown remarkable strength, with a 71.42% total return over the past year and a 32.9% return in the last three months. This performance supports RBC's decision to raise the price target and maintain an Outperform rating.

InvestingPro data reveals that IBM's revenue growth stands at 3.04% for the last twelve months, with a robust gross profit margin of 56.09%. These figures underscore the company's ability to generate strong cash flows, a point emphasized in RBC's analysis.

Two particularly relevant InvestingPro Tips highlight IBM's financial stability and market position. Firstly, IBM "has raised its dividend for 28 consecutive years," demonstrating a consistent return of value to shareholders. Secondly, it is noted as a "prominent player in the IT Services industry," which aligns with RBC's positive outlook on IBM's software traction and strategic positioning.

For investors seeking a deeper understanding of IBM's potential, InvestingPro offers 12 additional tips that could provide valuable insights into the company's future performance and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.